Incyte announces first patient treated in phase 3 trial program evaluating Ruxolitinib cream in patients with vitiligo

Image: Incyte announces first patient treated in phase 3 trial program evaluating Ruxolitinib cream in patients with vitiligo. Photo: courtesy of Belova59 from Pixabay.